European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.
published in: Haematologica
date of publication: 2016-07-14
Cites articles 11
Date
Title
Article - wd:Q42388539
Article - wd:Q42388539